Study name/lead author | Year published | No of patients enrolled (% of total eligible for enrollment) | Subsequent fracture rate in treatment arm (%) | Subsequent fracture rate in control arm (%) | Statistical significance reached | Follow-up period (weeks) |
VERTOS Voormolen et al 14 | 2007 | 34 | 11 | 0 | No | 2 |
FREE Wardlaw et al 15 | 2009 | 300 (49%) | 33* 47.5* | 25* 44.1* | No No | 52 104 |
INVEST Kallmes et al 16 | 2009 | 131 (30%) | NR | NR | NR | NR |
Buchbinder et al 17 | 2009 | 78 (36%) | 7.9 | 10 | No | 26 |
Rousing et al 18 | 2010 | 49 | 12 | 16.7 | No | 52 |
VERTOS II Klazen et al 19 | 2010 | 202 (47%) | 16.5 | 24.7 | No | 52 |
Farrokhi et al 20 | 2011 | 82 (100%) | 2.6 | 15.4 | Yes | 104 |
Blasco et al 21 | 2012 | 125 (100%) | 27 | 13 | Yes | 52 |
Chen et al 22 | 2014 | 96 | NR | NR | NR | NR |
Leali et al 23 | 2016 | 385 | 1.8 | 0 | No | 26 |
Yang et al 24 | 2016 | 135 (85%) | 8.9 | 7.8 | No | 52 |
Wang et al 25 | 2016 | 217 (69%) | 13 | 10 | No | 52 |
VOPE Hansen et al 28 | 2016 | 46 | NR | NR | NR | NR |
VAPOUR Clark et al 26 | 2016 | 120 (78%) | 6 | 4 | No | 26 |
VERTOS IV Firanescu et al 27 | 2018 | 180 (54%) | 39% | 37% | No | 52 |
*New or worsening radiographic vertebral fractures in follow-up.
NR, not reported.